--- title: Buy Lumigan + Applicators (Bimatoprost) 3ml Online description: Lumigan + Applicators (Bimatoprost) is a complete glaucoma treatment kit. Order from our secure online pharmacy for verified quality and reliable delivery. type: product language: en url: https://liabilis.com/order-lumigan_applicators-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 89.29 price_max: 455.99 currency: USD offers: - name: 3ml x 1 bottle price: 89.29 - name: 3ml x 3 bottles price: 237.49 - name: 3ml x 6 bottles price: 455.99 --- # Buy Lumigan + Applicators (Bimatoprost) 3ml Online This convenient kit combines Lumigan (Bimatoprost) eye drops with hygienic, disposable applicators. Developed by Allergan, Lumigan is used to treat glaucoma and ocular hypertension by reducing intraocular pressure. The included applicators help ensure precise, contamination-free application. Our online pharmacy offers a reliable way to access this complete Lumigan treatment kit with a 3ml bottle. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **3ml** | 1 bottle | **$89.29** | $89.29 | In Stock | | **3ml** | 3 bottles | **$237.49** | $79.16 | In Stock | | **3ml** | 6 bottles | **$455.99** | $76.00 | In Stock | [Buy Now](https://liabilis.com/order-lumigan_applicators-online-en.html) ## Introduction Lumigan + Applicators is a prescription ophthalmic solution containing the prostaglandin analogue bimatoprost. It is supplied in a 3 ml bottle equipped with a single-use applicator tip. The medication belongs to the class of intraocular pressure-lowering agents and is primarily indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. By decreasing IOP, Lumigan helps prevent optic nerve damage and preservation of visual function. ## Quick Reference Facts **Active Ingredient** : Bimatoprost **Form** : bottle 3 ml **Primary Uses** : • Lowering intraocular pressure in open-angle glaucoma • Management of ocular hypertension ## What is Lumigan + Applicators? Lumigan + Applicators is a branded ophthalmic solution marketed by Allergan (an AbbVie company). It delivers a precise dose of bimatoprost directly to the ocular surface via a disposable applicator tip, minimizing waste and ensuring accurate administration. As a brand product, Lumigan offers a formulation that has undergone extensive clinical testing to confirm safety, efficacy, and stability. Generic versions containing bimatoprost are available and may provide a lower-cost alternative, but the brand formulation remains a reference standard for clinicians. ## How Lumigan + Applicators Works Bimatoprost is a synthetic analogue of prostaglandin F₂α. After instillation into the conjunctival sac, it binds to prostaglandin receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. This increased outflow reduces the volume of fluid within the anterior chamber, thereby lowering IOP. The onset of pressure reduction typically occurs within 4 hours, with a peak effect at about 12 hours and sustained action over 24 hours, allowing once-daily dosing. Bimatoprost undergoes hepatic metabolism via cytochrome P450 enzymes and is eliminated primarily through the kidneys. ## Conditions Treated with Lumigan + Applicators - **Open-angle glaucoma** - The disease is characterized by impaired drainage of aqueous humor, leading to progressive optic nerve damage. Lumigan increases uveoscleral outflow, directly addressing the underlying pressure elevation. - **Ocular hypertension** - Patients have elevated IOP without detectable optic nerve injury. Early IOP control with Lumigan can prevent conversion to glaucoma. - **Secondary glaucoma (angle-closure prophylaxis)** - In selected cases where angle-closure risk is mitigated by IOP reduction, clinicians may use Lumigan off-label; however, this is not an approved indication. ## Is Lumigan + Applicators the Right Medication for You? Lumigan is suitable for adults diagnosed with open-angle glaucoma or ocular hypertension who require consistent IOP control. It is especially appropriate when once-daily dosing is preferred for adherence. Patients who have responded inadequately to beta-blockers or carbonic anhydrase inhibitors, or who experience systemic side effects from those classes, may benefit from switching to a prostaglandin analogue such as Lumigan. Contraindications include hypersensitivity to bimatoprost or any component of the formulation, active inflammation of the eye (e.g., uveitis), and pregnancy or breastfeeding unless the benefit outweighs risk. Caution is advised in patients with a history of herpetic keratitis, as prostaglandin analogues can precipitate reactivation. ## Buying Lumigan + Applicators from [our online pharmacy](https://liabilis.com/order-lumigan_applicators-online-en.html) ### Why Choose Our Service? Accessing specialty ophthalmic medications can be challenging due to high retail prices or limited pharmacy stock. Our platform provides a streamlined pathway to obtain Lumigan + Applicators at prices close to the manufacturer’s wholesale cost, alleviating financial barriers for patients who need long-term therapy. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. All shipments are sourced from establishments that comply with recognized regulatory frameworks such as the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA). ### Pricing & Access Because Lumigan is a brand product, it often carries a premium price tag in local markets. Through our service, you receive the same FDA-approved formulation at a reduced cost compared with many brick-and-mortar retailers. This makes sustained treatment financially feasible for many patients. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident containers to protect your privacy. Standard shipping typically arrives within seven days, while express options are available for faster receipt when needed. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - Instill one drop (approximately .005 ml) into the affected eye(s) once daily in the evening. The applicator tip delivers a measured dose to avoid over- or under-administration. - **Missed dose** - If a dose is forgotten, apply it as soon as remembered unless it is within two hours of the next scheduled dose. In that case, skip the missed dose and resume the regular evening schedule; do not double-dose. - **Overdose** - Accidental administration of more than one drop may cause transient ocular hyperemia, irritation, or blurred vision. If excessive dosing occurs, rinse the eye gently with sterile saline and seek medical attention if symptoms persist. - **Precautions** - Do not wear contact lenses immediately after instillation; wait at least 15 minutes. Avoid using other ophthalmic drops within five minutes of Lumigan to prevent dilution. Alcohol consumption does not interfere with efficacy, but patients should not operate heavy machinery if they experience vision changes after dosing. ## Safety Information ### ⚠️ Who Should Not Take Lumigan + Applicators - Known allergy to bimatoprost, any prostaglandin analogue, or formulation excipients (e.g., benzalkonium chloride). - Active ocular infection or severe inflammation (e.g., uveitis, keratitis). - Recent ocular surgery involving the cornea or sclera, unless cleared by the surgeon. - Pregnant or breastfeeding individuals without specialist approval. ### Common Side Effects - **Conjunctival hyperemia** (eye redness) - occurs in up to 70 % of patients; usually mild and transient. - **Eyelash changes** - increased length, thickness, or darkness; generally viewed as benign. - **Eye itching or foreign-body sensation** - often resolves within days of continued use. - **Mild ocular discomfort** - occasional burning or stinging on instillation. Management strategies include using preservative-free artificial tears, rotating the applicator tip, or discussing dose timing with a clinician. ### Serious Side Effects (Seek Immediate Medical Help) - **Persistent eye pain, vision loss, or sudden visual field changes** - may indicate acute angle-closure glaucoma. - **Severe ocular inflammation** - signs include marked swelling, photophobia, or discharge. - **Allergic reaction** - swelling of peri-ocular tissues, rash, or difficulty breathing. If any of these occur, discontinue use and obtain emergency ophthalmologic evaluation. ### Drug & Food Interactions - **Systemic carbonic anhydrase inhibitors** - additive IOP-lowering effect may increase risk of hypotony; monitor pressure closely. - **Topical corticosteroids** - may diminish the IOP-lowering response; adjust therapy as recommended. - **Non-steroidal anti-inflammatory drugs (NSAIDs)** - no clinically significant interaction reported, but ocular irritation may be additive. - **Food** - no known dietary interactions; however, excessive caffeine intake can transiently raise IOP in susceptible individuals. ## Off-Label and Investigational Uses of Lumigan + Applicators - **Eyelash hypotrichosis** - Clinical studies have shown that bimatoprost can stimulate regrowth of sparse eyelashes, leading to its approval for cosmetic use under the name Latisse. While Lumigan is not marketed for this purpose, some clinicians report off-label use for patients seeking therapeutic eyelash enhancement. - **Hair loss (alopecia)** - Small pilot studies suggest prostaglandin analogues may affect hair follicle cycling, but evidence remains limited and the formulation is not approved for scalp application. - **Neuroprotection in glaucoma** - Experimental models indicate potential protective effects on retinal ganglion cells beyond pressure reduction; human data are inconclusive. All off-label applications should be pursued only under direct supervision of an ophthalmologist or qualified healthcare professional. ## Storage & Handling - Store the bottle at controlled room temperature (20-25 °C / 68-77 °F). Do not freeze. - Protect from light; keep the container in its original opaque packaging until use. - Once opened, discard any remaining solution after 28 days, even if the expiry date on the label is later. - Dispose of empty bottles and applicators according to local pharmaceutical waste regulations; do not flush into the sewage system. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Lumigan + Applicators in my carry-on luggage?** Yes. Keep the bottle in its original packaging, place it in a resealable plastic bag, and comply with airline liquid limits (typically 100 ml). Declare it at security if requested. - **Will exposure to high heat, such as in a hot car, affect the medication?** Prolonged temperatures above 30 °C may degrade bimatoprost stability. Store the medication in a cool, dry place and avoid leaving it in a vehicle on sunny days. - **Is it safe to use Lumigan while wearing contact lenses?** Insert the drop before inserting lenses, and wait at least 15 minutes. Some patients experience lens discoloration; if this occurs, remove lenses, rinse the eye, and re-insert after another 15 minutes. **Product & Formulation Details** - **What does the applicator tip look like?** The disposable tip is a thin, plastic cannula terminates in a rounded nozzle designed to deliver a single .005 ml drop. It is pre-filled and sealed until first use. - **Are there preservatives in the solution?** Yes, the formulation contains benzalkonium chloride as a preservative to maintain sterility after opening. **Regulatory & Safety Nuances** - **Can athletes use Lumigan without violating anti-doping rules?** Bimatoprost is not listed as a prohibited substance by major sports organizations; however, athletes should verify with their governing body before use. - **Is Lumigan safe for elderly patients?** Age alone is not a contraindication, but older adults may be more prone to ocular surface irritation. Regular follow-up to monitor IOP and ocular health is advisable. **Scientific & Clinical Curiosity** - **How does Lumigan compare to other prostaglandin analogues like latanoprost?** Clinical trials have shown comparable IOP-lowering efficacy, with some studies indicating a modestly greater reduction with bimatoprost in certain patient subgroups. Side-effect profiles are similar, though hyperemia may be slightly more frequent with bimatoprost. - **What was the original development purpose of bimatoprost?** Bimatoprost was initially synthesized to treat glaucoma by enhancing uveoscleral outflow. Its effect on eyelash growth was discovered incidentally during clinical testing. ## Glossary **Uveoscleral outflow** : The drainage pathway for aqueous humor that passes through the ciliary muscle and into the suprachoroidal space, bypassing the conventional trabecular meshwork. **Prostaglandin analogue** : A synthetic compound that mimics the activity of naturally occurring prostaglandins, used to modulate physiological processes such as fluid dynamics in the eye. **Hyperemia** : Redness of the eye caused by increased blood flow to the conjunctival vessels, a common reversible side effect of prostaglandin eye drops. **Hypotony** : Abnormally low intraocular pressure, which can lead to visual disturbances and structural changes if pressure falls too far below normal levels. **Benzalkonium chloride** : A quaternary ammonium compound used as a preservative in ophthalmic solutions to prevent microbial contamination. ## Disclaimer The information provided about **Lumigan + Applicators** is intended for general educational purposes and does not substitute personalized medical advice. All therapeutic decisions, including those concerning off-label applications, should be made under the direct supervision of a qualified healthcare professional. Readers are presumed to be competent adults capable of evaluating health information responsibly. [our online pharmacy](https://liabilis.com/order-lumigan_applicators-online-en.html) makes **Lumigan + Applicators** accessible to individuals who may face limited availability or high costs through conventional channels, including those seeking more affordable generic alternatives. Consultation with a physician or ophthalmologist is essential before initiating, modifying, or discontinuing any medication.